GlassScriptPhysician profile
David A Henderson
NPI 1750332250
$64,380.45
in general payments reported to CMS, 2019-2025
41 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $4,063 · 2021: $36K · 2022: $2,700 · 2023: $1,742 · 2024: $1,737 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942 · Travel and Lodging: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,942.20 |
| Travel and Lodging | $1,898.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25,067.76 | 2019-2025 | Aveir, Amplatzer Amulet, Amplatzer Talisman |
| Esperion Therapeutics, INC. | $18,783.36 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $11,400.89 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $6,159.77 | 2019-2023 | |
| Cvrx, INC. | $418.24 | 2019-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $336.17 | 2019-2025 | |
| Medtronic, INC. | $330.11 | 2021-2024 | Onyx Frontier, In.Pact Admiral, Closurefast |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.13 | 2019-2023 | Jardiance |
| Amgen INC. | $241.52 | 2019-2022 | |
| Atricure, INC. | $237.50 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Philips North America LLC | $157.38 | 2019-2025 | (Cm9) Amb Mon & Diag Und, Epiq Cvx |
| Pfizer INC. | $155.70 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $77.18 | 2021-2024 | Optimizer, Optimizer |
| Novo Nordisk INC | $74.34 | 2021-2023 | Ozempic, Wegovy |
| Kestra Medical Technology Services, INC. | $69.46 | 2024-2025 | Assure Wcd |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $69.19 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $66.55 | 2019-2025 | Camzyos |
| Boston Scientific Corporation | $60.83 | 2019-2025 | Watchman Flx |
| Bardy Diagnostics, INC. | $47.50 | 2019-2021 | |
| Opsens INC. | $40.31 | 2019 | |
| Braemar Manufacturing, LLC | $38.08 | 2019 | |
| Merck Sharp & Dohme LLC | $35.98 | 2022 | |
| United Therapeutics Corporation | $34.27 | 2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $28.86 | 2020 | |
| Abiomed | $27.51 | 2024 | Impella |
| Acist Medical Systems, INC. | $26.07 | 2020 | |
| Irhythm Technologies, INC. | $25.24 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.51 | 2021 | |
| Infobionic, INC | $21.33 | 2024 | Mome Device |
| Amarin Pharma, INC. | $15.75 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.75 | 2019 | |
| Teleflex LLC | $14.65 | 2024 | Trapliner |
| Gilead Sciences, INC. | $14.42 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $12.97 | 2022 | |
| Elutia, INC. | $11.17 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.